Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Jeffrey

Showing results (521-530 of 651) with videos related to

Pageof 66
Sort By:
Neuron|September 13, 2016
Antipsychotic-like Effects of M4 Positive Allosteric Modulators Are Mediated by CB2 Receptor-Dependent Inhibition of Dopamine ReleaseDaniel J Foster, Jermaine M Wilson, Daniel H Remke, et al.
ACS Chemical Neuroscience|July 22, 2016
Development and Antiparkinsonian Activity of VU0418506, a Selective Positive Allosteric Modulator of Metabotropic Glutamate Receptor 4 Homomers without Activity at mGlu2/4 HeteromersColleen M Niswender, Carrie K Jones, Xin Lin, et al.
Journal of Medicinal Chemistry|September 25, 2018
Discovery, Structure-Activity Relationship, and Biological Characterization of a Novel Series of 6-((1 H-Pyrazolo[4,3- b]pyridin-3-yl)amino)-benzo[ d]isothiazole-3-carboxamides as Positive Allosteric Modulators of the Metabotropic Glutamate Receptor 4 (mGlu<sub>4</sub>)Sean R Bollinger, Darren W Engers, Joseph D Panarese, et al.
Molecular Pharmacology|May 2, 2009
A novel selective muscarinic acetylcholine receptor subtype 1 antagonist reduces seizures without impairing hippocampus-dependent learningDouglas J Sheffler, Richard Williams, Thomas M Bridges, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 2001
Phenyl benzenesulfonamides are novel and selective 5-HT6 antagonists: identification of N-(2,5-dibromo-3-fluorophenyl)-4-methoxy-3-piperazin-1-ylbenzenesulfonamide (SB-357134)S M Bromidge, S E Clarke, T Gager, et al.
Molecular Pharmacology|August 7, 2012
Investigating metabotropic glutamate receptor 5 allosteric modulator cooperativity, affinity, and agonism: enriching structure-function studies and structure-activity relationshipsKaren J Gregory, Meredith J Noetzel, Jerri M Rook, et al.
Bioorganic & Medicinal Chemistry Letters|May 15, 2018
The discovery of VU0486846: steep SAR from a series of M<sub>1</sub> PAMs based on a novel benzomorpholine coreJeanette L Bertron, Hyekyung P Cho, Pedro M Garcia-Barrantes, et al.
Bioorganic & Medicinal Chemistry Letters|November 22, 2000
Novel 2,3,4,5-tetrahydro-1H-3-benzazepines with high affinity and selectivity for the dopamine D3 receptorN E Austin, K Y Avenell, I Boyfield, et al.
Bioorganic & Medicinal Chemistry Letters|September 21, 2019
Discovery of a novel 3,4-dimethylcinnoline carboxamide M<sub>4</sub> positive allosteric modulator (PAM) chemotype via scaffold hoppingKayla J Temple, Julie L Engers, Madeline F Long, et al.
Inorganic Chemistry|May 13, 2008
Covalency trends in group IV metallocene dichlorides. chlorine K-edge X-ray absorption spectroscopy and time dependent-density functional theoryStosh A Kozimor, Ping Yang, Enrique R Batista, et al.
Pageof 66

Showing results (521-530 of 651) with videos related to

Sort By:
Pageof 66
Neuron|September 13, 2016
Antipsychotic-like Effects of M4 Positive Allosteric Modulators Are Mediated by CB2 Receptor-Dependent Inhibition of Dopamine ReleaseDaniel J Foster, Jermaine M Wilson, Daniel H Remke, et al.
ACS Chemical Neuroscience|July 22, 2016
Development and Antiparkinsonian Activity of VU0418506, a Selective Positive Allosteric Modulator of Metabotropic Glutamate Receptor 4 Homomers without Activity at mGlu2/4 HeteromersColleen M Niswender, Carrie K Jones, Xin Lin, et al.
Journal of Medicinal Chemistry|September 25, 2018
Discovery, Structure-Activity Relationship, and Biological Characterization of a Novel Series of 6-((1 H-Pyrazolo[4,3- b]pyridin-3-yl)amino)-benzo[ d]isothiazole-3-carboxamides as Positive Allosteric Modulators of the Metabotropic Glutamate Receptor 4 (mGlu<sub>4</sub>)Sean R Bollinger, Darren W Engers, Joseph D Panarese, et al.
Molecular Pharmacology|May 2, 2009
A novel selective muscarinic acetylcholine receptor subtype 1 antagonist reduces seizures without impairing hippocampus-dependent learningDouglas J Sheffler, Richard Williams, Thomas M Bridges, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 2001
Phenyl benzenesulfonamides are novel and selective 5-HT6 antagonists: identification of N-(2,5-dibromo-3-fluorophenyl)-4-methoxy-3-piperazin-1-ylbenzenesulfonamide (SB-357134)S M Bromidge, S E Clarke, T Gager, et al.
Molecular Pharmacology|August 7, 2012
Investigating metabotropic glutamate receptor 5 allosteric modulator cooperativity, affinity, and agonism: enriching structure-function studies and structure-activity relationshipsKaren J Gregory, Meredith J Noetzel, Jerri M Rook, et al.
Bioorganic & Medicinal Chemistry Letters|May 15, 2018
The discovery of VU0486846: steep SAR from a series of M<sub>1</sub> PAMs based on a novel benzomorpholine coreJeanette L Bertron, Hyekyung P Cho, Pedro M Garcia-Barrantes, et al.
Bioorganic & Medicinal Chemistry Letters|November 22, 2000
Novel 2,3,4,5-tetrahydro-1H-3-benzazepines with high affinity and selectivity for the dopamine D3 receptorN E Austin, K Y Avenell, I Boyfield, et al.
Bioorganic & Medicinal Chemistry Letters|September 21, 2019
Discovery of a novel 3,4-dimethylcinnoline carboxamide M<sub>4</sub> positive allosteric modulator (PAM) chemotype via scaffold hoppingKayla J Temple, Julie L Engers, Madeline F Long, et al.
Inorganic Chemistry|May 13, 2008
Covalency trends in group IV metallocene dichlorides. chlorine K-edge X-ray absorption spectroscopy and time dependent-density functional theoryStosh A Kozimor, Ping Yang, Enrique R Batista, et al.
Pageof 66